diphenhydramine hydrochloride has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Li, X; Liang, B; Shen, W; Yin, J | 1 |
| Giannakakou, P; Gupta, K; Joshi, HC; Panda, D; Yao, J; Ye, K; Zhou, J | 1 |
2 other study(ies) available for diphenhydramine hydrochloride and Cancer of Ovary
| Article | Year |
|---|---|
Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antitussive Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Mice; Mice, Inbred BALB C; Noscapine; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.
Topics: Alleles; Antineoplastic Agents, Phytogenic; Antitussive Agents; Apoptosis; Blotting, Western; Cell Death; Cell Division; Cell Nucleus; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Microscopy, Fluorescence; Microtubules; Mitogen-Activated Protein Kinases; Models, Chemical; Noscapine; Oligonucleotides, Antisense; Ovarian Neoplasms; Paclitaxel; Plasmids; Precipitin Tests; Protein Binding; Time Factors; Transfection; Tubulin; Tumor Cells, Cultured | 2002 |